M. Bernardo et al., Double-blind olanzapine vs. haloperidol D2 dopamine receptor blockade in schizophrenic patients: a baseline-endpoint [I-123]IBZM SPECT study, PSYCH RES-N, 107(2), 2001, pp. 87-97
The aim of this study was to compare in vivo striatal D2 dopamine receptor
occupancy induced by olanzapine and haloperidol in schizophrenic patients u
sing a baseline-endpoint [I-123]IBZM single photon computed emission tomogr
aphy (SPECT) design. The relationships of striatal D2 receptor occupancy wi
th clinical efficacy and extrapyramidal symptoms (EPS) were also assessed.
Twenty-seven inpatients with schizophrenia or schizophreniform. disorder we
re included in a 4-week prospective, randomized, double-blind, parallel and
comparative clinical trial. Thirteen patients were treated with haloperido
l (10 mg/day) and 14 with olanzapine (10 mg/day). Ratings of clinical statu
s and EPS were obtained weekly. The percentage of D2 receptor occupancy was
estimated by using basal ganglia (striatum)/frontal cortex IBZM uptake rat
ios obtained from each patient before and after 4 weeks of maintained antip
sychotic treatment. Olanzapine led to a mean striatal D2 receptor occupancy
of 49% (range 28-69%), which was significantly lower than that induced by
haloperidol (mean 64%, range 46-90%). The baseline-endpoint SPECT design us
ed in this study revealed lower antipsychotic D2 occupancy percentage value
s than those reported in the literature, using other approaches. The degree
of striatal D2 receptor occupancy correlated to the EPS, which predominant
ly appeared in patients on haloperidol. No relationship was found between t
he striatal D2 receptor occupancy and clinical improvement. Olanzapine indu
ced a lower striatal D2 occupancy than haloperidol. This low striatal D2 oc
cupancy, together with the lower incidence of EPS in olanzapine-treated pat
ients, contributed to confirm the atypical behavior of this now antipsychot
ic drug. Nevertheless, conclusions based on SPECT-estimated percentages of
antipsychotic D2 occupancy should be cautious, since the SPECT design could
influence the results. In this regard, SPECT studies including baseline an
d endpoint examinations should be encouraged. (C) 2001 Elsevier Science Ire
land Ltd. All rights reserved.